The authors studied 40 epileptic patients treated with valproate and 40 healthy controls for at least 2 years. At the end of follow-up, 15 epileptic patients (37.5%) had development of obesity. They showed circulating leptin and insulin levels significantly higher and ghrelin and adiponectin levels significantly lower than those of patients who did not gain weight. Copyright © 2005 by AAN Enterprises, Inc.
|Titolo:||Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid|
|Data di pubblicazione:||2005|
|Appare nelle tipologie:||1.1 Articolo in rivista|